By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera's second-quarter revenues dropped almost 21 percent, it reported after the close of market on Tuesday, missing consensus Wall Street estimates.

For the three months ended June 26, Celera recorded $32.6 million in revenues, down from $41.4 million in Q2 2009, and short of the $36 million expected by analysts.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.